Development and Validation of a Mortality Risk Prediction Model Using Large-Scale Data from 900,000 Korean Older Adults with Diabetes

Related

• Underweight is linked to higher kidney disease risk in diabetes

  Frontiers in Endocrinology · 4 Oct 2026

  

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• COVID-19 tied to higher dementia risk in older adults with diabetes

  Frontiers in Aging Neuroscience · 4 Oct 2026

• SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes

  Clinical Journal of the American Society of Nephrology · 4 Oct 2026